← Back to All Filings

Wasatch Advisors Reduces Stake in MacroGenics (MGNX) Below 5%

Medium SignificanceNovember 12, 2025 at 3:33:12 PM EST

MACROGENICS INC

$MGNXSCHEDULE 13G/ACIK: 0001125345

Subscribe to track MGNX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Wasatch Advisors Reduces Stake in MacroGenics (MGNX) Below 5%

Company: MACROGENICS INC (MGNX) Form: SCHEDULE 13G/A | Filed: 2025-11-12 Significance: Medium

Investor: Wasatch Advisors LP Title: Investment Adviser | Relationship: Beneficial Owner

Holdings Update: • Type: Change in Holdings • Shares Owned After: 1,950,287 • Ownership %: 3.1%

Key Insight: Institutional investor Wasatch Advisors has reduced its position in MGNX, falling below the 5% ownership reporting threshold. This signals a significant decrease in their holdings.

Market Context: For a nano-cap company like MGNX ($90M market cap), the reduction of a significant institutional stake can negatively impact investor sentiment and may warrant further investigation into the company's recent performance.

Comprehensive Analysis

SEC Filing Analysis: MACROGENICS INC (MGNX)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: Institutional investor Wasatch Advisors LP filed a Schedule 13G/A indicating its ownership in MacroGenics has fallen to 3.1%, dropping below the 5% reporting threshold.
  • Market Impact: This is a potentially bearish signal for the nano-cap stock, as it shows a significant institutional holder has been reducing its position.

Company Information

FieldValue
CompanyMACROGENICS INC
Ticker SymbolMGNX
CIK0001125345
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameWasatch Advisors LP
CIK0000814133
Title/PositionInvestment Adviser
RelationshipBeneficial Owner

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Transaction DateNot Applicable
Transaction CodeNot Applicable
Security TypeCommon Stock
Shares InvolvedNot specified
Price Per ShareNot specified
Total ValueNot specified
Shares Owned After1,950,287
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

This filing reports a change in aggregate holdings rather than a single transaction. The key event is the filer's ownership percentage dropping below the 5% threshold.

MetricValue
Post-Transaction Ownership1,950,287 shares
% of Shares Outstanding3.1%
Materiality AssessmentMedium

Impact Evaluation

  • Market Cap Context: MacroGenics is a nano-cap company with a market capitalization of approximately $90 million. In this context, the actions of institutional investors carry significant weight, and the exit of a major holder can create negative pressure on the stock.
  • Ownership Concentration: The filing indicates a decrease in institutional ownership concentration. The reduction of a position by a named fund like Wasatch Advisors can be a notable event for other market participants.
  • Transaction Significance: The significance lies not in a single transaction's value but in the strategic decision by an institutional investor to reduce their stake below a key reporting level. This implies the sale of a substantial number of shares over time, signaling a decreased conviction in the investment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While the reduction of a major stake is often a bearish indicator, this filing reports a state of ownership as of a past date (09/30/2025). The market may have already priced in the associated selling pressure. However, the official confirmation can still negatively influence sentiment.

Volume & Sentiment

  • Expected Volume Impact: Minimal direct impact, as the selling has already occurred. However, it could influence future trading decisions by other investors.
  • Sentiment Indicator: Neutral to Bearish. The news confirms that a significant institutional investor has been selling, which is a fundamentally bearish data point.

Investment Insights

Positive Market Indicators

  • None are indicated by this filing.

Risk Factors

  • Loss of Institutional Support: The reduction of Wasatch Advisors' stake below 5% signals a loss of conviction from a professional asset manager.
  • Potential for Further Selling: It is unknown if Wasatch Advisors has completely liquidated its position or intends to sell its remaining 3.1% stake.
  • Negative Signaling: For a small-cap biotech firm, such a move can be interpreted by the market as a negative signal regarding the company's pipeline, financial health, or future prospects.

Key Takeaways

  1. Stake Reduction: Wasatch Advisors is no longer a greater-than-5% beneficial owner of MacroGenics.
  2. Bearish Signal: The exit of a significant institutional holder is a noteworthy event that can weigh on investor sentiment, particularly for a nano-cap stock.
  3. Context is Key: This filing confirms a change that has already taken place. Investors should analyze it in the context of the company's recent performance and news to understand the potential drivers behind Wasatch's decision.

Additional Context

Transaction Notes

  • This Schedule 13G/A is an amendment to a prior filing, triggered by the filer's ownership level falling below 5%. The filing indicates a passive investment purpose, meaning the shares were not held to influence control of the company.
Topics:#SECFiling#Schedule13G#MGNX#MacroGenics#WasatchAdvisors#InstitutionalInvesting#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.